[
  {
    "date": "2023-06-30",
    "symbol": "PRNAF",
    "period": "FY",
    "cashandcashequivalents": 15773783,
    "tradeandothercurrentreceivables": 8665704,
    "othercurrentassets": 2609286,
    "currentassets": 27048773,
    "propertyplantandequipment": 61776,
    "rightofuseassets": 207087,
    "noncurrentassets": 268863,
    "assets": 27317636,
    "tradeandothercurrentpayables": 3517708,
    "currentprovisions": 729202,
    "currentleaseliabilities": 107177,
    "currenttaxliabilities": 27930,
    "currentliabilities": 4382017,
    "noncurrentprovisions": 19503,
    "noncurrentleaseliabilities": 103207,
    "noncurrentliabilities": 122710,
    "liabilities": 4504727,
    "netassetsliabilities": 22812909,
    "issuedcapital": 213971323,
    "reserveofsharebasedpayments": 3972475,
    "retainedearnings": -195130889,
    "equity": 22812909,
    "accumulateddepreciationpropertyandequipment": 181681,
    "accumulateddepreciationofrightuseofassets": 278245,
    "numberofsharesissuedandfullypaid": 2439897618,
    "revenuefrominterest": 16436,
    "otherincome": 3916333,
    "intellectualpropertyexpenses": 285067,
    "generalandadministrativeexpense": 5056571,
    "researchanddevelopmentexpense": 13198583,
    "miscellaneousotheroperatingexpense": 29404,
    "othergainslosses": 917650,
    "forfeitedoptionsfromreserves": 17150,
    "profitlossbeforetax": -13702056,
    "incometaxexpensecontinuingoperations": 104459,
    "profitloss": -13806515,
    "comprehensiveincome": -13806515,
    "basicearningslosspershare": -0.57,
    "weightedaverageshares": 2427841917,
    "dilutedearningslosspershare": -0.57,
    "adjustedweightedaverageshares": 2427841917,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 19943617,
    "interestreceivedclassifiedasoperatingactivities": 15798,
    "interestpaidclassifiedasoperatingactivities": 4565,
    "incometaxespaidrefund": 103453,
    "cashflowsfromusedinoperatingactivities": -20035837,
    "paymentsforrentalsecuritydeposits": 29150,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 7311,
    "cashflowsfromusedininvestingactivities": -36461,
    "proceedsfromissueofsecuritiesandotherequitysecurities": 316675,
    "paymentsforshareissuecosts": 132413,
    "principleelementsofleasepayments": 59922,
    "cashflowsfromusedinfinancingactivities": 124340,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -19947958,
    "effectofexchangeratechangesoncashandcashequivalents": 914942,
    "numberofsharesoutstanding": 2439897618,
    "issuanceofsharesnetofcostsvalue": 316675,
    "issuanceofsharesnetofcostsshares": 33023040,
    "increasedecreasethroughissuanceofoptionstoemployees": 983721,
    "increasedecreasethroughsharebasedpaymenttransactions": -132413,
    "increasedecreasethroughoptionsexpiredinsharebasedpaymentarrangement": -560014,
    "forfeitedoptionsreversedtoprofitorloss": -17150,
    "increasedecreasethroughtransactionswithowners": 184262,
    "transactionswithownersintheircapacityasownersinshares": 33023040,
    "descriptionofaccountingpolicyforbasisofconsolidationexplanatorypolicytextblock": "(a) Principles of Consolidation",
    "descriptionofaccountingpolicyforrecognitionofotherincome": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in\"><b>(m) Interest income</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Other income is made up of interest income which is recognised on atime proportion basis using the effective interest method.</p>",
    "descriptionofaccountingpolicyforcomparativefiguresexplanatorypolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\"><b>(u) Comparative Figures</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Comparative figures, are, where appropriate, reclassified to be comparablewith figures presented in the current financial year.</p>",
    "descriptionofaccountingpolicyfornewaccountingstandardsandinterpretationspolicytextblock": "(v) New Accounting Standards and Interpretations",
    "disclosureoftradeandotherreceivabletabletextblock": "Years Ended June 30,             2023      2022                            Accrued interest income      656       18       R&D tax incentive receivable (1)      8,583,635       4,669,405       Goods and services tax receivable      16,184       55,938       Accounts receivable      65,229       -       Total Trade and Other Receivables      8,665,704       4,725,361",
    "scheduleoftradeandotherpayabletabletextblock": "Years Ended June 30,             2023      2022                            Trade creditors      1,716,135       2,689,098       Accrued research and development expenses      1,458,310       2,066,500       Accrued professional fees      222,126       185,362       Other accrued expenses      87,223       107,929       Other payables      33,914       57,622                              Total      3,517,708       5,106,511",
    "disclosureofmovementsofeachclassofprovisionexplanatorytabletextblock": "Movements in each class of provision during the financial year areset out below:",
    "scheduleofamountsnotexpectedtobesettledwithinthenext12monthstable": "The following amounts reflect leave that is notexpected to be taken or paid within the next 12 months.",
    "scheduleofreconciliationofnumberofsharesoutstandingtabletextblock": "Movements in Issued Shares",
    "scheduleofdetailsofissuanceofsharecapitaltabletextblock": "Details of share issuances are as follows:",
    "scheduleofreserveofsharebasedpaymentstabletextblock": "Years Ended June 30,             Notes     2023      2022      2021                                         (a) Share Based Payments                                    170,042,720 (2022: 184,692,720, 2021: 160,542,720) options for fully paid ordinary shares     11(c)      3,972,475       3,565,918       2,750,884                                                         3,972,475       3,565,918       2,750,884",
    "scheduleofmovementsinoptionsforfullypaidordinarysharestabletextblock": "Movements in Options for Fully Paid Ordinary Shares",
    "scheduleofamountsrelatingtoleasestabletextblock": "The statement of financial position shows the following amounts relatingto leases:",
    "disclosureofamountsrecognizedinprofitorlossrelatingleases": "The statement of profit or loss shows the following amounts relatingto leases:",
    "scheduleofoptionsoutstandingexpirydateandexercisepricestabletextblock": "Options outstanding at the end of the year have the following expirydate and exercise prices:",
    "scheduleofvaluationsofoptionsapprovedandissuedtabletextblock": "The model inputs for the valuations of options approved and issuedduring the current and previous financial years are as follows:",
    "scheduleofnumberofsharesissuedtabletextblock": "Information with respect to the number of shares issued under the stockoption plan as follows:",
    "disclosureofkeymanagementpersonnelcompensationtabletextblock": "Years Ended June 30,             2023      2022      2021                                   Short-term employee benefits      1,727,020       1,641,015       1,891,777       Post-employment benefits      42,444       44,121       45,180       Long-term benefits      7,215       6,711       (110,285)      Termination benefits      -       -       1,000,000       Share-based payments      764,175       998,164       1,950,565              2,540,854       2,690,011       4,777,237",
    "scheduleofauditorremunerationtabletextblock": "Years Ended June 30,             2023      2022      2021                                   - Audit and review of financial statements (1)      246,400       216,400       202,400       - Other audit services (2)      52,000       -       130,000                                             298,400       216,400       332,400",
    "scheduleofequityholdingsofkeymanagementpersonneltabletextblock": "Key Management Personnel Equity Holdings",
    "disclosureofcurrencyrisktabletextblock": "The following financial assets and liabilities are subject to foreigncurrency risk, the currency of the original amounts are displayed in brackets, all the amounts in the table below are displayed in A$at year-end spot rates:",
    "scheduleofinterestratesforclassesoffinancialassetsandliabilitiestabletextblock": "The Group’s exposure to interest rates and the effective weightedaverage interest rate for classes of financial assets and liabilities is set out below:",
    "scheduleofliquidityreservetabletextblock": "Management monitors rolling forecasts of the Group’s liquidityreserve on the basis of expected cash flows. See Note 1 (Going Concern Basis) of our accompanying financial statements.",
    "otherrevenue": 16436,
    "researchanddevelopmenttaxincentive": 3914230,
    "miscellaneousotheroperatingincome": 2103,
    "revenueandoperatingincome": 3932769,
    "employeebenefitsexpense": 2720345,
    "otherresearchanddevelopmentexpenses": 10478238,
    "depreciationexpense": 37854,
    "depreciationrightofuseassets": 64409,
    "otheremployeeexpense": 926314,
    "consultantanddirectorexpenses": 320500,
    "auditinternalcontrolandotherassuranceexpenses": 238728,
    "corporatecomplianceexpenses": 457215,
    "insuranceexpense": 721732,
    "rentalexpense": 68634,
    "administrativeexpense": 1032843,
    "sharebasedpaymentexpenses": 966571,
    "corporateadvisoryexpenses": 204621,
    "foreignexchangegainloss01": -917650,
    "currenttaxexpenseincome": 33808,
    "adjustmentsforcurrenttaxofpriorperiod": 70651,
    "taxexpenseincomeatapplicabletaxrate": -3446718,
    "taxeffectofforeigntaxrates": -6440,
    "taxeffectofresearchanddevelopmentexpenditure": 1267940,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 413976,
    "taxeffectofdeferredtaxassetnotrecognized": 1805050,
    "incometaxexpenseattributabletolossbeforeincometax": -104459,
    "deferredtaxassets": 44056899,
    "temporarydifferencesassociatedwithinvestmentsinsubsidiariesbranchesandassociatesandinterestsinjointventures": 3675742,
    "primafacietaxonnetlossbeforeincometax": 0.25,
    "currentaccruedincomeincludingcurrentcontractassets": 656,
    "researchanddevelopmenttaxincentivereceivable": 8583635,
    "paymentstosuppliersforgoodsandservices": 16184,
    "tradeandotherreceivables": 65229,
    "currentprepayments": 2569522,
    "othercurrentfinancialassets": 39764,
    "tradeandothercurrentpayablestotradesuppliers": 1716135,
    "accruedresearchanddevelopmentexpenses": 1458310,
    "accruedprofessionalfees": 222126,
    "othercurrentaccruedexpenses": 87223,
    "otherpayables": 33914,
    "tradeandothercurrentpayable": 3517708,
    "provisions": 420380,
    "increasedecreasethroughtransfersandotherchangesotherprovisions": 272502,
    "additionalprovisionsotherprovisions": 232747,
    "increasedecreasethroughforeignexchangefinancialassets": 8748,
    "annualleaveandlongserviceleavecarryingamount": 748705,
    "amountsexpectedtobesettledaftertwelvemonths": 19503,
    "paidordinaryshares": 213971323,
    "movementduringtheyearnoofsharesinshares": 33023040,
    "valueofincreasedecreaseinsharesoutstanding": 184262,
    "endoftheyearnoofshares": 2439897618,
    "issuedcapitalendoftheyear": 213971323,
    "increasedecreaseinnumberofshareoutstanding": 33023040,
    "issuedcapitalpreferenceshares": 184262,
    "numberofsharesissuedduringtheyear": "Issue of shares under ATM Facility",
    "increasedecreaseinnumberofsharesoutstanding": 9543840,
    "parvaluepershare": 0.0135,
    "issuedcapitalpreferenceshare": 128842,
    "optionsforfullypaidordinaryshares1": 170042720,
    "freeattachingoptionsforfullypaidordinaryshares": 674694939,
    "numberofsharesoptionsoutstanding": 170042720,
    "sharebasedpaymentnumberofoptionsoptionsexpiredduringtheyearindollarspershare": -13150000,
    "reserveofsharebasedpaymentsexpiredduringtheyear": -560014,
    "numberofoptionsforfeitedduringtheyear": -1500000,
    "reserveofsharebasedpaymentsforfeitedduringyear": -17150,
    "expensefromsharebasedpaymenttransactionswithemployees": 983721,
    "retainedearning": 195130889,
    "profitlossattributabletoownersofparent": 13806515,
    "reclassifyexpiredoptionsfromreservesone": 560014,
    "leaseliabilities": 210384,
    "interestexpense": 4565,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 68634,
    "adjustmentsfordepreciationexpense": 37854,
    "adjustmentsfornoncashissueofequityinconsiderationofoperatingexpenses": 966571,
    "foreignexchangegainloss": -917650,
    "deferredtaxliabilityasset": 10232,
    "increasedecreaseintradeandotherreceivables": -3940343,
    "adjustmentsfordecreaseincreaseinothercurrentassets": -968207,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -1560873,
    "adjustmentsforprovisions": 78685,
    "cashonhand": 15773783,
    "cashequivalents": 15773783,
    "numberofshareoptionoutstandinginsharebasedpaymentarrangement": 170042720,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.05,
    "numberofshareoptionexpiredinsharebasedpaymentarrangement": 13150000,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement": 0.11,
    "numberofshareoptionlapsedinsharebasedpaymentarrangement": 1500000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentsarrangement": 0.02,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement": 0.05,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 87280755,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement": 0.06,
    "dateofgrantofsharebasedpaymentarrangement": "December 18, 2017",
    "expirydateofoutstandingshareoptions": "December 14, 2022",
    "exercisepriceofoutstandingshareoption1": 0.11,
    "numberofoutstandingsharesoption": 35000000,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P2Y6M10D",
    "exercisepriceshareoptionsgranted2019": 0.07,
    "sharepriceatgrantdate": 0.05,
    "yearstoexpiry": "P5Y",
    "riskfreeinterestrate": 0.0197,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1,
    "fairvalueperoptions": 0.034,
    "numberofshares": 13277715,
    "basicearningslosspersharefromcontinuingoperations": -0.57,
    "weightedaveragenumberofordinarysharesonissueusedinthecalculationofbasic": 2427841917,
    "dilutedearningslosspersharefromcontinuingoperations": -0.57,
    "weightedaveragenumberofordinarysharesonissueusedinthecalculationofdiluted": 2427841917,
    "shorttermemployeebenefits": 1727020,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 42444,
    "keymanagementpersonnelcompensationotherlongtermbenefit": 7215,
    "keymanagementpersonnelcompensationsharebasedpayments": 764175,
    "keymanagementpersonnelcompensation": 2540854,
    "auditorsremunerationforauditservices": 246400,
    "auditorsremunerationforotherservices": 52000,
    "auditorsremuneration": 298400,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 63348,
    "keymanagementpersonnelcompensationbonus": 194570,
    "otherkeymanagementpersonnel": 6652,
    "longtermbenefitslongservicesleave": 7215,
    "keymanagementpersonnelcompensationsharebasedpayment": 764175,
    "managementpersonnelcompensation": 70000,
    "numberofshareoptionoutstanding": 18011000,
    "numberofsharesissuedother": 3555000,
    "numberofshareoptionsoutstanding": 14000000,
    "numberofshareoptionsexpired": -5000000,
    "vestedandexercisable": 14000000,
    "totalunvested": 3750000,
    "financialinstrumentstotalexposure": 15473231,
    "financialassets": 27457,
    "averageinterestrate": 0.0005,
    "financialliabilities": -107177,
    "tradeandotherpayables": 3517708,
    "taxrateeffectfromchangesintaxrate": "A 43.5% refundable tax offset will be available to eligible small companies with an annual aggregateturnover of less than $20 million.",
    "eligibleamountunderthetaxincentivescheme": 3900000,
    "profitlossbeforetax1": 13806515,
    "profitlossbeforetax2": 20035837,
    "estimatedusefuleconomiclife": "P3Y",
    "employeesdescription": "Employees",
    "taxrateeffectfromchangeintaxrate": 0.435,
    "turnoverrevenue": 20000000,
    "eligibleamountundertaxincentivescheme": 3914230,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducecurrenttaxexpense": 164311376,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 2976920,
    "eligibleamountundertaxincentiveschemes": 3363433,
    "reserveofordinaryshares": 600,
    "additionstorightofuseassets": 152817,
    "cashoutflowforleases": 133121,
    "shorttermleaseterm": "12 months",
    "terminationnoticeperiodforresearchanddevelopmentcontracts": "P30D",
    "researchanddevelopmentterminationcommitments": 3700000,
    "numberofdirector": 4,
    "numberofpreviousdirector": 2,
    "numberofemployees": 9,
    "numberofkeymanagementpersonnel": 3,
    "percentageofdefaultvestingconditionsperyear": 0.25,
    "proportionofownershipinterestinsubsidiary": 1,
    "professionalfeesexpense": 202800,
    "numberofreportablesegment": 1,
    "averageannualmovementforeignexchangerate": 0.036,
    "sensitivityanalysisofposttaxprofitimpactofpercentchangeinaustraliandollaragainstusdollar": 499159,
    "cash": 27457,
    "percentageofinterestrate": 0.0144,
    "entityregistrantname": "ALTERITY THERAPEUTICS LIMITED",
    "tradingsymbol": "ATHE",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--06-30",
    "entitycommonstocksharesoutstanding": 2439897618,
    "amendmentflag": "false",
    "entitycentralindexkey": 1131343,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-49843",
    "entityincorporationstatecountrycode": "C3",
    "entityaddressaddressline1": "Level 14, 350 Collins Street",
    "entityaddresscityortown": "Melbourne",
    "entityaddresspostalzipcode": 3000,
    "entityaddresscountry": "AU",
    "contactpersonnelname": "David Stamler",
    "cityareacode": 61,
    "localphonenumber": "3 9349 4906",
    "security12btitle": "American Depositary Shares, each representing 600 Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PricewaterhouseCoopers",
    "auditorlocation": "Australia",
    "auditorfirmid": 1379
  }
]